123696澳门论坛

HNHE China 2021 was held in Hainan province from November 12-14. Dr. HAN Shuhua, Chief Scientific Officer, and Mr. CHEN Wende, Chief Operating Officer, of Genor Biopharma were invited to attend the conference and deliver speeches at the forums.

Dr. GUO Feng, existing Executive Director and Chief Executive Officer, Genor Biopharma, has been appointed Chairman of the company. Meanwhile, the Board further announced that Dr. LYU Dong, currently the managing director of Zhuhai Gao Ling Equity Investment Management Co., Ltd. is appointed as a non-executive Director of Genor Biopharma.

The Asia Biopharma Industry Innovation Summit 2021, hosted by Taas Labs, kicked off in Shanghai on October 28. Dr. Joe ZHOU, Founder & President of Genor Biopharma, delivered an opening speech with the theme of "Current Status and Trends of Antibody Drug Development: BsAb." He shared his views on the changes in the biopharmaceutical industry, the current status of China's drug regulatory environment, and the opportunities and challenges in the development of biologic drugs. He also introduced the progress of Genor Biopharma bispecific/multi-specific antibodies.

Mr. LIANG Qibin, the former President of CMAB Biopharma, will join Genor Biopharma as Chief Technology Officer. With Mr. LIANG Qibin joining the company, it will further strengthen the innovation ability of core technologies and achieve efficient innovation in technology, research and development, processes, management and other areas.

2020 Chinese Biopharma Companies Innovation TOP 100 Series Lists were officially released during China BioMed Innovation and Investment Conference, Genor Biopharma was included in the Chinese Antibody Drug Companies Innovation TOP 30.